Home › Funds › Renaissance Technologies › GILD
Renaissance Technologies position in GILD
GILEAD SCIENCES INC · Health Care
Renaissance Technologies reported holding 2,054,876 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$306.3M, representing 0.42% of its reported portfolio and ranking #31 among its reported holdings. Renaissance Technologies has disclosed GILD holdings in 51 of the last 54 reported quarters, going back to Q2 2013.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Renaissance Technologies's GILD position evolved
Renaissance Technologies first disclosed a stake in GILD in Q2 2013 at 196,248 shares (US$10.1M). The position peaked in Q4 2019 at 16,962,944 shares, worth US$1.10B. Across 51 filings, Renaissance Technologies increased the stake 23 time(s), trimmed it 25 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,054,876 shares valued at US$306.3M — a reduction of -162,500 shares quarter over quarter.. Notable position changes include a 328% increase in Q1 2015, a 727% increase in Q4 2015, a 171% increase in Q4 2016.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2013 | 196.25K | $10.06M | New |
| Q1 2014 | 189.35K | $13.42M | New |
| Q2 2014 | 166.65K | $13.82M | Reduce |
| Q4 2014 | 941.40K | $88.74M | New |
| Q1 2015 | 4.03M | $395.67M | Add |
| Q2 2015 | 1.31M | $153.39M | Reduce |
| Q3 2015 | 280.30K | $27.52M | Reduce |
| Q4 2015 | 2.32M | $234.71M | Add |
| Q1 2016 | 723.95K | $66.50M | Reduce |
| Q2 2016 | 1.08M | $90.04M | Add |
| Q3 2016 | 1.95M | $154.05M | Add |
| Q4 2016 | 5.27M | $377.74M | Add |
| Q1 2017 | 7.71M | $523.48M | Add |
| Q2 2017 | 10.41M | $736.67M | Add |
| Q3 2017 | 10.23M | $828.91M | Reduce |
| Q4 2017 | 7.56M | $541.95M | Reduce |
| Q1 2018 | 5.03M | $379.42M | Reduce |
| Q2 2018 | 2.75M | $194.98M | Reduce |
| Q3 2018 | 4.49M | $346.65M | Add |
| Q4 2018 | 5.39M | $337.12M | Add |
| Q1 2019 | 8.12M | $527.90M | Add |
| Q2 2019 | 12.74M | $860.73M | Add |
| Q3 2019 | 14.73M | $933.86M | Add |
| Q4 2019 | 16.96M | $1.10B | Add |
| Q1 2020 | 12.53M | $936.83M | Reduce |
| Q2 2020 | 8.90M | $684.86M | Reduce |
| Q3 2020 | 7.65M | $483.52M | Reduce |
| Q4 2020 | 6.37M | $371.39M | Reduce |
| Q1 2021 | 6.56M | $424.04M | Add |
| Q2 2021 | 5.05M | $347.56M | Reduce |
| Q3 2021 | 5.50M | $384.24M | Add |
| Q4 2021 | 9.08M | $659.45M | Add |
| Q1 2022 | 15.49M | $921.01M | Add |
| Q2 2022 | 13.41M | $828.85M | Reduce |
| Q3 2022 | 10.02M | $618.29M | Reduce |
| Q4 2022 | 9.20M | $790.04M | Reduce |
| Q1 2023 | 10.58M | $878.17M | Add |
| Q2 2023 | 7.78M | $599.71M | Reduce |
| Q3 2023 | 6.44M | $482.87M | Reduce |
| Q4 2023 | 5.58M | $451.70M | Reduce |
| Q1 2024 | 4.32M | $316.27M | Reduce |
| Q2 2024 | 5.06M | $347.00M | Add |
| Q3 2024 | 4.19M | $351.17M | Reduce |
| Q4 2024 | 5.33M | $492.31M | Add |
| Q1 2025 | 5.45M | $610.80M | Add |
| Q2 2025 | 5.67M | $628.23M | Add |
| Q3 2025 | 5.46M | $606.36M | Reduce |
| Q4 2025 | 2.79M | $342.29M | Reduce |
| Q1 2026 | 2.15M | $300.00M | Reduce |
| Q2 2026 | 2.22M | $280.14M | Add |
| Q3 2026 | 2.05M | $306.28M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 58.27M sh · $8.68B · Q3 2026
- Invesco Ltd 38.66M sh · $5.76B · Q3 2026
- Capital World Investors 35.93M sh · $5.36B · Q3 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Capital Research Global Investors 23.98M sh · $3.57B · Q3 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
- MFS Investment Management 11.46M sh · $1.77B · Q3 2026
- Amundi US 11.26M sh · $1.68B · Q3 2026
- Deutsche Bank AG 9.61M sh · $1.43B · Q3 2026
- Boston Partners 6.52M sh · $970.37M · Q3 2026
More on Renaissance Technologies
FAQ
How long has Renaissance Technologies held GILD?
Renaissance Technologies has disclosed GILD holdings in 51 of the last 54 reported quarters, going back to Q2 2013.
What is Renaissance Technologies's current position in GILD?
As of Q3 2026, Renaissance Technologies holds 2.05M shares of GILD (GILEAD SCIENCES INC), valued at $306.28M, representing 0.42% of its reported portfolio and ranking #31.
Has Renaissance Technologies been buying or selling GILD?
In the latest 13F filing (Q3 2026), Renaissance Technologies reduced its position in GILD. The position peaked in Q4 2019 at 16.96M shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.